S100B gene polymorphisms predict prefrontal spatial function in both schizophrenia patients and healthy individuals

Schizophrenia Research

Volumn 134, Issue 1, 2012, Pages 89-94

  Zhai, Jinguo ^a   Cheng, Lina ^b   Dong, Jicheng ^c   Shen, Qiuge ^b   Zhang, Qiumei ^a   Chen, Min ^a   Gao, Li ^a   Chen, Xiongying ^b   Wang, Keqin ^a   Deng, Xiaoxiang ^b   Xu, Zhansheng ^b   Ji, Feng ^a   Liu, Chuanxin ^a   Li, Jun ^b   Dong, Qi ^b   Chen, Chuansheng ^d  

^a JINING MEDICAL UNIVERSITY   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

^c SHANDONG MENTAL HEALTH CENTER   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Executive control; S100B; Schizophrenia; SNP; Spatial working memory

Indexed keywords

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; S100B GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE; WORKING MEMORY;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NERVE GROWTH FACTORS; POLYMORPHISM, SINGLE NUCLEOTIDE; S100 PROTEINS; SCHIZOPHRENIA; SPACE PERCEPTION;

EID: 84155166854     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.09.029     Document Type: Article

References (36)

1. Ando J., Ono Y., Wright M.J. Genetic structure of spatial and verbal working memory. Behav. Genet. 2001, 31(6):615-624.
2. Bertolino A., Taurisano P., Pisciotta N.M., Blasi G., Fazio L., Romano R., Gelao B., Lo Bianco L., Lozupone M., Di Giorgio A., Caforio G., Caforio G. Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance. PLoS One 2010, 5(2):e9348.
3. Blokland G.A., McMahon K.L., Hoffman J., Zhu G., Meredith M., Martin N.G., Thompson P.M., de Zubicaray G.I., Wright M.J. Quantifying the heritability of task-related brain activation and performance during the N-back working memory task: a twin fMRI study. Biol. Psychol. 2008, 79(1):70-79.
4. Breton F., Planté A., Legauffre C., Morel N., Adès J., Gorwood P., Ramoz N., Dubertret C. The executive control of attention differentiates patients with schizophrenia, their first-degree relatives and healthy controls. Neuropsychologia 2011, 49(2):203-208.
5. Callicott J.H., Ramsey N.F., Tallent K., Bertolino A., Knable M.B., Coppola R., Goldberg T., van Gelderen P., Mattay V.S., Frank J.A., Moonen C.T., Weinberger D.R. Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 1998, 18(3):186-196.
6. Cannon T.D., Huttunen M.O., Lonnqvist J., Tuulio-Henriksson A., Pirkola T., Glahn D., Finkelstein J., Hietanen M., Kaprio J., Koskenvuo M. The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am. J. Hum. Genet. 2000, 67(2):369-382.
7. Chajut E., Schupak A., Algom D. Are spatial and dimensional attention separate? Evidence from Posner, Stroop, and Eriksen tasks. Mem. Cognit. 2009, 37(6):924-934.
8. Ehlis A.C., Reif A., Herrmann M.J., Lesch K.P., Fallgatter A.J. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders. Neuropsychopharmacology 2007, 32(1):162-170.
9. Ehrenreich H., Hinze-Selch D., Stawicki S., Aust C., Knolle-Veentjer S., Wilms S., Heinz G., Erdag S., Jahn H., Degner D., Ritzen M., Mohr A., Wagner M., Schneider U., Bohn M., Huber M., Czernik A., Pollmächer T., Maier W., Sirén A.L., Klosterkötter J., Falkai P., Rüther E., Aldenhoff J.B., Krampe H. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol. Psychiatry 2007, 12(2):206-220.
10. Fan J., McCandliss B.D., Sommer T., Raz A., Posner M.I. Testing the efficiency and independence of attentional networks. J. Cogn. Neurosci. 2002, 14(3):340-347.
11. Fan J., Flombaum J.I., McCandliss B.D., Thomas K.M., Posner M.I. Cognitive and brain consequences of conflict. Neuroimage 2003, 18(1):42-57.
12. Gerlai R., Wojtowicz J.M., Marks A., Roder J. Overexpression of a calcium-binding protein, S100 beta, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice. Learn. Mem. 1995, 2(1):26-39.
13. Glahn D.C., Ragland J.D., Abramoff A., Barrett J., Laird A.R., Bearden C.E., Velligan D.I. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum. Brain Mapp. 2005, 25(1):60-69.
14. Hohoff C., Ponath G., Freitag C.M., Kastner F., Krakowitzky P., Domschke K., Koelkebeck K., Kipp F., von Eiff C., Deckert J., Rothermundt M. Risk variants in the S100B gene predict elevated S100B serum concentrations in healthy individuals. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B(1):291-297.
15. Hyun J.S., Luck S.J. Visual working memory as the substrate for mental rotation. Psychon. Bull. Rev. 2007, 14(1):154-158.
16. Jansen A., Krach S., Krug A., Markov V., Eggermann T., Zerres K., Stocker T., Shah N.J., Nothen M.M., Treutlein J., Rietschel M., Kircher T. A putative high risk diplotype of the G72 gene is in healthy individuals associated with better performance in working memory functions and altered brain activity in the medial temporal lobe. Neuroimage 2009, 45(3):1002-1008.
17. Kravariti E., Toulopoulou T., Mapua-Filbey F., Schulze K., Walshe M., Sham P., Murray R.M., McDonald C. Intellectual asymmetry and genetic liability in first-degree relatives of probands with schizophrenia. Br. J. Psychiatry 2006, 188:186-187.
18. Lara D.R., Gama C.S., Belmonte-de-Abreu P., Portela L.V., Goncalves C.A., Fonseca M., Hauck S., Souza D.O. Increased serum S100B protein in schizophrenia: a study in medication-free patients. J. Psychiatr. Res. 2001, 35(1):11-14.
19. Liu J., Shi Y., Tang J., Guo T., Li X., Yang Y., Chen Q., Zhao X., He G., Feng G., Gu N., Zhu S., Liu H., He L. SNPs and haplotypes in the S100B gene reveal association with schizophrenia. Biochem. Biophys. Res. Commun. 2005, 328(1):335-341.
20. Liu M.E., Hong C.J., Liou Y.J., Tsai Y.L., Hsieh C.H., Tsai S.J. Association study of a functional catechol-O-methyltransferase polymorphism and executive function in elderly males without dementia. Neurosci. Lett. 2008, 436(2):193-195.
21. Nishiyama H., Knopfel T., Endo S., Itohara S. Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(6):4037-4042.
22. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 2004, 74(4):765-769.
23. Opgen-Rhein C., Neuhaus A.H., Urbanek C., Hahn E., Sander T., Dettling M. Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test. Schizophr. Bull. 2008, 34(6):1231-1239.
24. Osinsky R., Schmitz A., Alexander N., Kuepper Y., Kozyra E., Hennig J. TPH2 gene variation and conflict processing in a cognitive and an emotional Stroop task. Behav. Brain Res. 2009, 198(2):404-410.
25. Pirkola T., Tuulio-Henriksson A., Glahn D., Kieseppa T., Haukka J., Kaprio J., Lonnqvist J., Cannon T.D. Spatial working memory function in twins with schizophrenia and bipolar disorder. Biol. Psychiatry 2005, 58(12):930-936.
26. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81(3):559-575.
27. Roder J.K., Roder J.C., Gerlai R. Conspecific exploration in the T-maze: abnormalities in S100 beta transgenic mice. Physiol. Behav. 1996, 60(1):31-36.
28. Rothermundt M., Missler U., Arolt V., Peters M., Leadbeater J., Wiesmann M., Rudolf S., Wandinger K.P., Kirchner H. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol. Psychiatry 2001, 6(4):445-449.
29. Rothermundt M., Ponath G., Arolt V. S100B in schizophrenic psychosis. Int. Rev. Neurobiol. 2004, 59:445-470.
30. Schmitt A., Bertsch T., Henning U., Tost H., Klimke A., Henn F.A., Falkai P. Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms. Schizophr. Res. 2005, 80(2-3):305-313.
31. Schroeter M.L., Abdul-Khaliq H., Krebs M., Diefenbacher A., Blasig I.E. Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia-original research and meta-analysis. Psychiatry Res. 2009, 167(1-2):66-72.
32. Steiner J., Bernstein H.G., Bielau H., Farkas N., Winter J., Dobrowolny H., Brisch R., Gos T., Mawrin C., Myint A.M., Bogerts B. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. J. Psychiatr. Res. 2008, 42(10):868-876.
33. Stephens M., Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 2003, 73(5):1162-1169.
34. Yadavalli S., Gunstad J., Glickman E., Alexander T., Spitznagel M.B., Juvancic-Heltzel J., Murray L., Collinsworth T. Increased S100beta is associated with reduced cognitive function in healthy older adults. Neuropsychobiology 2008, 57(3):121-125.
35. Zhai J., Zhang Q., Cheng L., Chen M., Wang K., Liu Y., Deng X., Chen X., Shen Q., Xu Z., Ji F., Liu C., Dong Q., Chen C., Li J. Risk variants in the S100B gene, associated with elevated S100B levels, are also associated with visuospatial disability of schizophrenia. Behav. Brain Res. 2011, 217(2):363-368.
36. Zhang X.Y., Xiu M.H., Song C., Chen D.C., Wu G.Y., Haile C.N., Kosten T.A., Kosten T.R. Increased serum S100B in never-medicated and medicated schizophrenic patients. J. Psychiatr. Res. 2010, 222(2):326-331.